Lv3
226 积分 2022-01-13 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
3个月前
已完结
In vivo CAR T cells gain traction, with AbbVie’s US$2.1 billion acquisition of Capstan Therapeutics
3个月前
已完结
In Vitro and In Vivo Activity of a Lipid Nanoparticle System for the In Vivo Generation of CAR T Cells
3个月前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
3个月前
已完结
Generation of a neutralizing antibody against RD114-pseudotyped viral vectors
7个月前
已完结
皖公网安备34019202002308
